iRhythm Holdings, Inc.

IRTC Healthcare Medical Devices

iRhythm Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $747.1 million, up 26.2% from fiscal 2024.

Revenue
+14.9%
EPS
−462.5%
Free cash flow
−157.6%
Total debt
+0.48%

Quarter to September 2026, against a year earlier

90.26 39.93 −30.67%
Market cap
$4.3B
P/E
0.0×
Fwd P/E
−311×
Dividend yield
—
F-score
5/9
Altman Z
4.02
Beneish M
−3.04
Dividend safety
n/a

iRhythm Holdings, Inc. (IRTC) P/E ratio

Alert me on P/E ratio

iRhythm Holdings, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period P/E ratio Change
Sep 2026 0.0× —
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
40 more quarters

Against its own ten years

Low 0.0× High 0.0×
Ten-year median 0.0×
Current reading's percentile 100

P/E ratio against peers

Company P/E ratio
NEOG Neogen Corporation compare n/m
AXGN AxoGen, Inc. compare n/m
IRTC iRhythm Holdings, Inc. n/m
TXG 10x Genomics compare n/m
TMDX TransMedics Group, Inc. compare 16.4×
LIVN LivaNova PLC compare 25.6×
UFPT UFP Technologies, Inc. compare 30.1×
ITGR Integer Holdings Corporation compare 42.2×
HAE Haemonetics Corporation compare 54.5×
Medical Devices industry median 25.6×
Healthcare sector median 25.2×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on IRTC